16-GU-69-AS (9785-MA-1010) A Randomized Study of Enzalutamide in Patients with Localized Prostate Cancer Undergoing Active Surveillance (ENACT)

Grants and Contracts Details

StatusFinished
Effective start/end date6/1/16 → 12/31/16

Funding

  • Astellas Pharma Global Development Incorporated: $8,600.00